HERBORIUM GROUP Announces Investor Awareness Campaign

SADDLE BROOK, N.J., Feb. 7, 2012 /PRNewswire/ -- Herborium Group, Inc., (Pink Sheets: HBRM) www.herborium.com, aBotanical Therapeutics® company, announces today its plan to launch an aggressive Investors Awareness Campaign beginning Feb. 7th 2012 to continue throughout 2012. Strategies and programs are designed to increase mass market awareness of the Company among individual investors, institutions, analysts along with financing injections.     

Dr. Agnes Olszewski, Chairmen and CEO of Herborium stated: "We are most excited to confirm that we are beginning the next step in our business plan to foster  growth and to increase shareholder value and trading volume. Also, as a part of growing our market presence and sales we have announced 2012 - Year Without Acne.

"Our Social Media Strategy that commenced in Summer of 2011 is already bringing results.  Our 2011 Internet sales grew 6.5%.  Number of our twitter followers doubled since December 2011 and we have scheduled numerous Social Media events on our own and with new partners to keep the momentum going.  We will share those developments with our shareholders in upcoming weeks.

"AcnEase®, www.acnease.com, our unique all botanical therapeutic®  for Acne is gaining a strong following. Over 130 million people are affected by Acne in the US and Europe alone.  Herborium'sAcnEase® results are very impressive, with up to 95% of both females and males seeing significant improvement after the first course of treatment," added  Dr. Olszewski.

"In addition to progress in brand building and growing sales of AcnEase  Herborium is  developing  platform to develop sales of its other Botanical Therapeutics®

"We have a number of existing, proprietary, patented, or trade secret protected, natural medicinal products that are uniquely qualified to address highly important health concerns.

"During the recent months significant progress has been made to identify a proper partners and distribution channels in the US and abroad to commercialize those products,"  concluded  Dr. Olszewski.

About Herborium Group, Inc.

Herborium Group, Inc., a Botanical Therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals.  The Company uses clinical validation to establish and maintain a differential advantage. The company sales its products in the US and Europe. For more information, please visit www.herborium.com and www.acnease.com. 

One of our most important responsibilities is to communicate with shareholders in an open and direct manner.  Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends."  We cannot promise future returns.  Our statements reflect our best judgment at the time, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events.  The Company urges investors to review the risks and uncertainties contained within its filings with the OTC Markets and/or Securities and Exchange Commission.

For more information please inquire:
Herborium Group, Inc.
Investorsrelations@herborium.com